DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.77% to $7.23 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.51% to 19,100.94 and Dow Jones Industrial Average falling 0.58% to 42,098.70.
This was the stock's third consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 88.32% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.46% to $4.31, Fortress Biotech Inc. (FBIO) rose 3.83% to $1.90, and Viking Therapeutics Inc. $(VKTX)$ fell 0.18% to $27.13.
Trading volume (92,609) remained 80,290 below its 50-day average volume of 172,899.
Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 28, 2025 17:25 ET (21:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。